Carregant...
Estimating progression-free survival in paediatric brain tumour patients when some progression statuses are unknown
In oncology, progression-free survival time, which is defined as the minimum of the times to disease progression or death, often is used to characterize treatment and covariate effects. We are motivated by the desire to estimate the progression time distribution on the basis of data from 780 paediat...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3298417/ https://ncbi.nlm.nih.gov/pubmed/22408277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1467-9876.2011.01002.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|